MedTrace Logo

Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection

NCT02326636 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2023-08-21

No results posted yet for this study

Summary

The purpose of this research is to investigate the efficacy of transplanting screened donor fecal material in treating patients with recurrent Clostridium difficile infection. Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema and their response will be evaluated by symptom questionnaire and stool testing for Clostridium difficile at 4 weeks after the treatment.

Conditions

  • Clostridium Difficile Infection

Interventions

BIOLOGICAL

Fecal Microbial Transplantation

Participants with refractory Clostridium difficile infection will be given healthy donor stool administered by colonoscopy or enema.

Sponsors & Collaborators

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Nimisha Parekh, MD · University of California, Irvine

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-10-26
Completion
2018-10-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02326636 on ClinicalTrials.gov